Bispecific Antibody Meets Antibody-Drug Conjugate in Promising Small Cell Lung Cancer Trial
First clinical data from the Phase 1b/2 BNT324-01 trial show that the investigational combination of pumitamig and elfetabart drozuntecan achieved ...
First clinical data from the Phase 1b/2 BNT324-01 trial show that the investigational combination of pumitamig and elfetabart drozuntecan achieved ...
A major new review finds that symptomatic therapies for Alzheimer disease, from cholinesterase inhibitors to personalized psychosocial care, deliver meaningful ...
Egyptian researchers found that the alcohol-aversion drug disulfiram synergizes with fluconazole, downregulates the Cdr1 efflux pump, and inhibits biofilm formation ...
A new meta-analysis finds that combining SGLT2 inhibitors with GLP-1 receptor agonists is associated with lower risks of myocardial infarction ...
A new review maps how the CD73-adenosine axis drives immune suppression in non-small cell lung cancer and how blocking it ...
A new mouse study finds that combining the PARP inhibitor olaparib with radiotherapy improves tumor control in oral squamous cell ...
A new analysis published in npj Parkinson’s Disease considers how combination therapies might better slow or modify Parkinson’s disease—an approach ...
In triple-negative breast cancer (TNBC) that carries TP53 mutations, loss of one copy of the DNA ligase I gene (LIG1) ...
In the evolving landscape of cancer treatment, the intricate interaction between immune cells and tumor microenvironments remains a focal point ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine